170 related articles for article (PubMed ID: 23458763)
1. Treating multidrug-resistant Acinetobacter baumannii infection by blocking its virulence factors.
López-Rojas R; Smani Y; Pachón J
Expert Rev Anti Infect Ther; 2013 Mar; 11(3):231-3. PubMed ID: 23458763
[No Abstract] [Full Text] [Related]
2. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.
Gordon NC; Wareham DW
Int J Antimicrob Agents; 2010 Mar; 35(3):219-26. PubMed ID: 20047818
[TBL] [Abstract][Full Text] [Related]
3. Acinetobacter baumannii: an emerging multidrug-resistant threat.
Gootz TD; Marra A
Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
[TBL] [Abstract][Full Text] [Related]
4. Minocycline: an old drug for a new bug: multidrug-resistant Acinetobacter baumannii.
Goff DA; Kaye KS
Clin Infect Dis; 2014 Dec; 59 Suppl 6():S365-6. PubMed ID: 25371511
[No Abstract] [Full Text] [Related]
5. Are we closing in on an "elusive enemy"? The current status of our battle with Acinetobacter baumannii.
Perez F; Ponce-Terashima R; Adams MD; Bonomo RA
Virulence; 2011; 2(2):86-90. PubMed ID: 21499025
[No Abstract] [Full Text] [Related]
6. Confronting multidrug-resistant Acinetobacter baumannii: a review.
Neonakis IK; Spandidos DA; Petinaki E
Int J Antimicrob Agents; 2011 Feb; 37(2):102-9. PubMed ID: 21130607
[TBL] [Abstract][Full Text] [Related]
7. Acinetobacter baumannii resistant to everything: what should we do?
Vila J; Pachón J
Clin Microbiol Infect; 2011 Jul; 17(7):955-6. PubMed ID: 21722248
[No Abstract] [Full Text] [Related]
8. The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting.
Hanlon GW
Lett Appl Microbiol; 2005; 41(5):375-8. PubMed ID: 16238638
[TBL] [Abstract][Full Text] [Related]
9. Role of combination antibiogram in empirical treatment of infection due to multidrug-resistant Acinetobacter baumannii.
Apisarnthanarak A; Mundy LM
Infect Control Hosp Epidemiol; 2008 Jul; 29(7):678-9. PubMed ID: 18624670
[No Abstract] [Full Text] [Related]
10. Successful treatment of multidrug resistant Acinetobacter baumannii meningitis.
Saçar S; Turgut H; Cenger DH; Coşkun E; Asan A; Kaleli I
J Infect Dev Ctries; 2007 Dec; 1(3):342-4. PubMed ID: 19734617
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic options for Acinetobacter baumannii infections.
Vila J; Pachón J
Expert Opin Pharmacother; 2008 Mar; 9(4):587-99. PubMed ID: 18312160
[TBL] [Abstract][Full Text] [Related]
12. Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis.
Tutuncu EE; Kuscu F; Gurbuz Y; Ozturk B; Haykir A; Sencan I
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e224-6. PubMed ID: 19962335
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin.
Katragkou A; Roilides E
J Clin Microbiol; 2005 Sep; 43(9):4916-7. PubMed ID: 16145177
[No Abstract] [Full Text] [Related]
14. Antibacterial activity of carbapenem-based combinations againts multidrug-resistant Acinetobacter baumannii.
Pongpech P; Amornnopparattanakul S; Panapakdee S; Fungwithaya S; Nannha P; Dhiraputra C; Leelarasamee A
J Med Assoc Thai; 2010 Feb; 93(2):161-71. PubMed ID: 20301995
[TBL] [Abstract][Full Text] [Related]
15. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
[TBL] [Abstract][Full Text] [Related]
16. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
Cai Y; Chai D; Wang R; Liang B; Bai N
J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date.
Durante-Mangoni E; Utili R; Zarrilli R
Future Microbiol; 2014; 9(6):773-89. PubMed ID: 25046524
[TBL] [Abstract][Full Text] [Related]
18. Advances in the way of dealing with antibiotic exposure in studies assessing risk factors for drug-resistant pathogens.
Prates CG; Zavascki AP
Diagn Microbiol Infect Dis; 2009 May; 64(1):102; author reply 103. PubMed ID: 19232855
[No Abstract] [Full Text] [Related]
19. Treatment of Acinetobacter infections.
Michalopoulos A; Falagas ME
Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
[TBL] [Abstract][Full Text] [Related]
20. Biology of
Lee CR; Lee JH; Park M; Park KS; Bae IK; Kim YB; Cha CJ; Jeong BC; Lee SH
Front Cell Infect Microbiol; 2017; 7():55. PubMed ID: 28348979
[No Abstract] [Full Text] [Related]
[Next] [New Search]
